Valuation: PROCEPT BioRobotics Corporation

Market Cap 1.24B 1.06B 995M 911M 1.71B 119B 1.73B 11.76B 4.59B 59.68B 4.66B 4.56B 197B P/E 2026 *
-13.1x
P/E 2027 * -19.7x
Enterprise Value 1.12B 956M 894M 819M 1.54B 107B 1.56B 10.56B 4.12B 53.62B 4.19B 4.1B 177B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.34x
Free-Float
96.72%
Yield 2026 *
-
Yield 2027 * -
1 day+4.58%
1 week+0.14%
Current month+16.43%
1 month+17.06%
3 months-25.06%
6 months-20.50%
Current year-31.09%
1 week 20.69
Extreme 20.69
22.2
1 month 16.66
Extreme 16.665
22.93
Current year 16.66
Extreme 16.665
35.4
1 year 16.66
Extreme 16.665
42.43
3 years 16.66
Extreme 16.665
103.81
5 years 15.38
Extreme 15.38
103.81
10 years 15.38
Extreme 15.38
103.81
Manager TitleAgeSince
Chief Executive Officer 60 2025-09-01
Director of Finance/CFO 48 2018-09-30
Chief Operating Officer 56 2026-02-28
Director TitleAgeSince
Chairman 74 2021-02-28
Director/Board Member 48 2015-05-31
Director/Board Member 50 2020-11-30
Date Insider Type Main position Quantity % Market Cap.
8/13/26 Free

General Counsel

54,738 0.0962%
8/13/26 Free

Responsable ventes & marketing

56,303 0.0989%
8/13/26 Free

Chief Financial Officer

70,378 0.1236%
Change 5-day change 1-year change 3-year change Capi.($)
+4.58%+0.14%-44.90%-29.54% 1.24B
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average +1.70%+0.26%+3.46%+11.52% 60.15B
Weighted average by Cap. +1.54%+1.90%+1.86%+17.77%

Financials

2026 *2027 *
Net sales 395M 339M 317M 290M 544M 37.83B 552M 3.74B 1.46B 19.01B 1.48B 1.45B 62.86B 477M 408M 382M 350M 657M 45.63B 665M 4.52B 1.76B 22.92B 1.79B 1.75B 75.81B
Net income -94.7M -81.12M -75.9M -69.48M -130M -9.06B -132M -897M -350M -4.55B -356M -348M -15.06B -63M -53.96M -50.49M -46.22M -86.74M -6.03B -87.88M -597M -233M -3.03B -237M -231M -10.01B
Net Debt -126M -108M -101M -92.46M -174M -12.06B -176M -1.19B -465M -6.06B -473M -463M -20.03B -125M -107M -99.95M -91.49M -172M -11.93B -174M -1.18B -460M -5.99B -468M -458M -19.82B
Logo PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.
Employees
888
Date Price Change Volume
26-08-21 US$21.68 +4.58% 821,951
26-08-20 US$20.73 -5.39% 1,293,434
26-08-19 US$21.91 +2.77% 635,988
26-08-18 US$21.32 +1.09% 819,529
26-08-17 US$21.09 -2.59% 998,800
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
21.68USD
Average target price
21.64USD
Spread / Average Target
-0.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRCT Stock